Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Clinical studies have confirmed that AOD-9604 does not stimulate IGF-1 production in any biological system tested, including human clinical trials monitoring serum IGF-1 levels over 24-week treatment periods
Lindsay Testimonials It was excellent
She treats GLP-1 as scaffolding for building metabolic habits, not a permanent prescription
120,000+ Farmer Members 185 Million+ Network Acres $2.5 Billion Financed 100,000+ Input Deliveries 6,000 Seed Profiles Hear Why Farmers Trust FBN - FBN recognizes the importance of farmers
Epigenetic and Cellular Reprogramming: By blocking NNMT-mediated methylation of nicotinamide, preserves NAD salvage pathway activity, increases SIRT-1 signaling, reduces histone deacetylation, and promotes metabolic reprogramming toward oxidative phosphorylation and glycolysis balance, supporting tissue repair and energy homeostasis 1-4
Each component (BPC-157, TB-500) is not FDA-approved and was removed from 503B bulk-compounding eligibility in 2024
US$ 29.69
US$ 24.27
US$ 20.85
US$ 23.80
